ATC completes Rs3,800-crore mobile tower deal with Vodafone India
ATC Telecom Infrastructure has completed the purchase of Vodafone India’s telecom site business, which consists of approximately 10,200 communications sites
New Delhi: Telecom infrastructure firm American Tower Corp. (ATC) on Tuesday announced that it has completed mobile tower purchase deal worth Rs3,800 crore with Vodafone India through its Indian arm.
ATC Telecom Infrastructure, a majority owned Indian subsidiary of ATC, has completed the purchase of Vodafone India’s telecom site business, which consists of approximately 10,200 communications sites, ATC said in a statement.
“We are pleased to acquire this portfolio, which will complement our existing footprint and help us serve our tenants in India as they expand 4G services in the coming years,” said Amit Sharma, ATC’s executive vice president and president for Asia.
Completion of this deal brings the approval of Idea and Vodafone merger closer. The closure of approximately Rs4,000-crore mobile tower sale deal between ATC and Idea is now awaited. According to government sources, the merger of Idea and Vodafone will be cleared after the closure of Idea’s pending deal with ATC.
“We expect regulatory processes to be completed by end of this month (for closure of deal with Idea). The Department of Telecom is driving it. We are hopeful of completing the deal by May,” Sharma said.
The purchase of Vodafone mobile towers adds nearly 10,200 mobile network sites to the existing Indian portfolio. The two deals are expected to generate approximately Rs2,100 crore in property revenue and approximately Rs800 crore in gross margin during their first full year in ATC’s portfolio, as per the announcement earlier made by the company.
- Write-offs at PSBs grow at faster clip than loan growth
- Monetary policy panel cites inflationary risks as reason for RBI rate hike
- Vivo invests ₹200 crore to ramp up manufacturing at Greater Noida facility
- Ad agency Rediffusion to launch new logo, vision
- CSIR lab develops potential clot buster drug for stroke, licences it for clinical trials
Editor's Picks »
- Q1 results: Apollo Hospitals is back on investors’ radar
- RBI MPC minutes show its ready for trade wars, global market turmoil
- Recent rise in trade deficit is not due to the oil prices
- Safeguard duty proposal has deepened uncertainty in the solar energy sector
- Fortis Healthcare: What now, after IHH entry and June quarter loss?